Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRO
CRO
Charles River pays $470M for 2 Frontage labs in Pennsylvania
Frontage stands to receive additional payments of up to $75 million contingent on future performance.
Marissa Russo
Nov 13, 2026 11:00am
Rivia launches AI-powered clinical trial data review
Nov 11, 2026 1:00pm
Start opens first early-phase cancer trial site in Italy
Nov 10, 2026 12:41pm
Charles River teams up with Ipsen for toxicology studies
Nov 4, 2026 2:25pm
nPhase rakes in $30M to expand AI-native clinical data platform
Nov 4, 2026 8:21am
BMS joins 3-year collab to boost cancer trial participation
Oct 27, 2026 5:00am